Published in Proc Natl Acad Sci U S A on April 01, 1989
Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest (1994) 7.25
The plasminogen activator/plasmin system. J Clin Invest (1991) 4.20
92-kD type IV collagenase mediates invasion of human cytotrophoblasts. J Cell Biol (1991) 2.79
Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? J Cell Biol (1996) 2.21
Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc Natl Acad Sci U S A (1989) 2.12
Obstructive nephropathy: insights from genetically engineered animals. Kidney Int (2005) 1.97
Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. J Clin Invest (2005) 1.89
Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers. Am J Pathol (1996) 1.72
Impaired wound contraction in stromelysin-1-deficient mice. Ann Surg (1999) 1.67
Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. Proc Natl Acad Sci U S A (1996) 1.66
Single-molecule tracking of collagenase on native type I collagen fibrils reveals degradation mechanism. Curr Biol (2012) 1.63
Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds. J Clin Invest (1994) 1.52
Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis. Am J Pathol (1997) 1.51
Transin/stromelysin expression in rheumatoid synovium. A transformation-associated metalloproteinase secreted by phenotypically invasive synoviocytes. Am J Pathol (1989) 1.50
Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme. Protein Sci (1995) 1.50
A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis. J Clin Invest (2003) 1.42
In vivo paracrine interaction between urokinase and its receptor: effect on tumor cell invasion. J Cell Biol (1991) 1.33
Matrix metalloproteinase control of capillary morphogenesis. Crit Rev Eukaryot Gene Expr (2008) 1.32
Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase. J Clin Invest (1996) 1.27
Matrix metalloproteases: underutilized targets for drug delivery. J Drug Target (2007) 1.21
Oxidative and nitrosative stress and fibrogenic response. Clin Liver Dis (2008) 1.09
Expression of SPARC during development of the chicken chorioallantoic membrane: evidence for regulated proteolysis in vivo. Mol Biol Cell (1995) 1.06
Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells. Cell Regul (1990) 1.06
Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor. J Cell Biol (1991) 1.06
Coordinate synthesis of stromelysin, interleukin-1, and oncogene proteins in experimental osteoarthritis. An immunohistochemical study. Am J Pathol (1993) 1.05
Cell surface remodeling by plasmin: a new function for an old enzyme. J Biomed Biotechnol (2012) 1.04
Direct activation of human neutrophil procollagenase by recombinant stromelysin. Biochem J (1993) 1.03
Always cleave up your mess: targeting collagen degradation to treat tissue fibrosis. Am J Physiol Lung Cell Mol Physiol (2013) 1.02
Transin/stromelysin expression in the synovium of rats with experimental erosive arthritis. In situ localization and kinetics of expression of the transformation-associated metalloproteinase in euthymic and athymic Lewis rats. J Clin Invest (1989) 1.01
Interstitial collagenase gene expression in oral squamous cell carcinoma. Am J Pathol (1992) 1.01
Density-dependent induction of 92-kd type IV collagenase activity in cultures of A431 human epidermoid carcinoma cells. Am J Pathol (1994) 1.00
The gelatin-binding site of human 72 kDa type IV collagenase (gelatinase A). Biochem J (1994) 1.00
Increased expression levels of integrin alphavbeta5 on scleroderma fibroblasts. Am J Pathol (2004) 0.98
Activation of precursors for matrix metalloproteinases 1 (interstitial collagenase) and 3 (stromelysin) by rat mast-cell proteinases I and II. Biochem J (1995) 0.97
Progestin-inflammatory cytokine interactions affect matrix metalloproteinase-1 and -3 expression in term decidual cells: implications for treatment of chorioamnionitis-induced preterm delivery. J Clin Endocrinol Metab (2007) 0.97
MMPs are less efficient than ADAMTS5 in cleaving aggrecan core protein. Matrix Biol (2010) 0.96
The fibrinolytic system in dissemination and matrix protein deposition during a mycobacterium infection. Am J Pathol (2003) 0.93
Acquisition of plasmin activity by Fusobacterium nucleatum subsp. nucleatum and potential contribution to tissue destruction during periodontitis. Infect Immun (1999) 0.93
Heterogeneous suppression of experimentally induced colon cancer metastasis in rat liver lobes by inhibition of extracellular cathepsin B. Clin Exp Metastasis (1998) 0.92
The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer. Thorax (1999) 0.90
Allele-specific regulation of matrix metalloproteinase-3 gene by transcription factor NFkappaB. PLoS One (2010) 0.88
Soluble urokinase receptor released from human carcinoma cells: a plasma parameter for xenograft tumour studies. Br J Cancer (1999) 0.87
Prostaglandin E2 acts via multiple receptors to regulate plasminogen-dependent proteolysis in the primate periovulatory follicle. Endocrinology (2008) 0.87
Characterization of helical cleavages in type II collagen generated by matrixins. Biochem J (1998) 0.86
Myocardial remodeling in viral heart disease: possible interactions between inflammatory mediators and MMP-TIMP system. Heart Fail Rev (2004) 0.85
Increased PAI-1 in females compared with males is protective for abdominal aortic aneurysm formation in a rodent model. Am J Physiol Heart Circ Physiol (2012) 0.85
Ovulation efficiency is reduced in mice that lack plasminogen activator gene function: functional redundancy among physiological plasminogen activators. Proc Natl Acad Sci U S A (1995) 0.83
Bradykinin and alpha-thrombin increase human umbilical vein endothelial macromolecular permeability by different mechanisms. Inflammation (2000) 0.83
Transformation-dependent activation of urokinase-type plasminogen activator by a plasmin-independent mechanism: involvement of cell surface membranes. Proc Natl Acad Sci U S A (1991) 0.83
Ovarian expression and regulation of the stromelysins during the periovulatory period in the human and the rat. Biol Reprod (2012) 0.82
Modulation of urokinase and urokinase receptor gene expression in human renal cell carcinoma. Am J Pathol (1995) 0.82
The plasminogen system in regulating stem cell mobilization. J Biomed Biotechnol (2012) 0.81
Proteolytic action of kallikrein-related peptidase 7 produces unique active matrix metalloproteinase-9 lacking the C-terminal hemopexin domains. Biochim Biophys Acta (2011) 0.81
Hepatocyte growth factor stimulates the invasion of gallbladder carcinoma cell lines in vitro. Clin Exp Metastasis (1998) 0.80
Characterization of the functional domain of tissue inhibitor of metalloproteinases-2 (TIMP-2). Biochem J (1993) 0.80
Ceramide 1-phosphate mediates endothelial cell invasion via the annexin a2-p11 heterotetrameric protein complex. J Biol Chem (2013) 0.79
Matrix metalloproteinase-10 is a target of T and B cell responses that correlate with synovial pathology in patients with antibiotic-refractory Lyme arthritis. J Autoimmun (2016) 0.79
Type 1 plasminogen activator inhibitor gene expression following partial hepatectomy. Am J Pathol (1993) 0.78
Role of proteases in pancreatic carcinoma. World J Surg (2005) 0.77
Augmentation by eosinophils of gelatinase activity in the airway mucosa: comparative effects as a putative mediator of epithelial injury. Br J Pharmacol (1996) 0.77
Matrix metalloproteinase-1 activation via plasmin generated on alveolar epithelial cell surfaces. Lung (2006) 0.77
Decoy plasminogen receptor containing a selective Kunitz-inhibitory domain. Biochemistry (2014) 0.76
Adenoviral gene transfer of angiostatic ATF-BPTI inhibits tumour growth. BMC Cancer (2002) 0.75
Plasminogen Deficiency Delays the Onset and Protects from Demyelination and Paralysis in Autoimmune Neuroinflammatory Disease. J Neurosci (2017) 0.75
Body weight and vascular invasion in post-menopausal women with breast cancer. Br J Cancer (1997) 0.75
The enzyme profiles in the connective tissue attaching pin bones to the surrounding tissue is specific in farmed salmon (Salmo salar) and cod (Gadus morhua L.). Fish Physiol Biochem (2016) 0.75
Human Aortic Vascular Smooth Muscle Cells Digest Extracellular Matrix by Elaboration of Plasminogen Activators: Implications for Atherogenesis. J Thromb Thrombolysis (1995) 0.75
The influence of antiestrogens on the release of plasminogen activator (uPA) by MDA-MB-231 and MCF-7 breast cancer cells. Clin Exp Metastasis (1998) 0.75
Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J Biol Chem (1987) 34.69
A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots. Anal Biochem (1984) 22.53
Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med (1985) 8.16
H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem (1988) 4.06
Endogenous activiation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator. N Engl J Med (1977) 3.81
Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem (1986) 3.67
Epidermal growth factor and oncogenes induce transcription of the same cellular mRNA in rat fibroblasts. EMBO J (1985) 3.60
Stromelysin, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase. Biosynthesis, isolation, characterization, and substrates. J Biol Chem (1985) 3.51
Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest (1986) 3.43
Comparison of human stromelysin and collagenase by cloning and sequence analysis. Biochem J (1986) 3.31
Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. J Biol Chem (1986) 3.24
Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J Biol Chem (1985) 3.15
Biochemical interactions of tumor cells with the basement membrane. Annu Rev Biochem (1986) 3.06
A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization. J Biol Chem (1986) 2.65
Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes. Biochem J (1987) 2.54
Human skin collagenase: isolation of precursor and active forms from both fibroblast and organ cultures. Biochemistry (1977) 2.39
Evidence that latent collagenases are enzyme-inhibitor complexes. Biochem J (1977) 2.32
Interleukin 1 stimulation of collagenase production by cultured fibroblasts. J Exp Med (1983) 2.28
Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells. Proc Natl Acad Sci U S A (1987) 1.89
The activation of human skin fibroblast procollagenase. Sequence identification of the major conversion products. J Biol Chem (1987) 1.78
Interleukin 1 gene expression in cultured human keratinocytes is augmented by ultraviolet irradiation. J Clin Invest (1987) 1.69
The complete primary structure of human matrix metalloproteinase-3. Identity with stromelysin. J Biol Chem (1988) 1.54
A gene for rabbit synovial cell collagenase: member of a family of metalloproteinases that degrade the connective tissue matrix. Biochemistry (1987) 1.52
The collagen substrate specificity of human neutrophil collagenase. J Biol Chem (1987) 1.49
Regulation of the mammalian collagenases. Coll Relat Res (1984) 1.49
Human skin fibroblast collagenase: chemical properties of precursor and active forms. Biochemistry (1978) 1.47
Human fibroblast collagenase: glycosylation and tissue-specific levels of enzyme synthesis. Proc Natl Acad Sci U S A (1986) 1.44
Purification of an endogenous activator of procollagenase from rabbit synovial fibroblast culture medium. J Biol Chem (1983) 1.42
Human skin fibroblast procollagenase: mechanisms of activation by organomercurials and trypsin. Biochemistry (1983) 1.39
A specific inhibitor of vertebrate collagenase produced by human skin fibroblasts. J Biol Chem (1979) 1.37
Modulation of keratinocyte proliferation in vitro by endogenous prostaglandin synthesis. J Clin Invest (1986) 1.31
Evidence that human rheumatoid synovial matrix metalloproteinase 3 is an endogenous activator of procollagenase. Arch Biochem Biophys (1988) 1.24
The collagen substrate specificity of rat uterus collagenase. J Biol Chem (1983) 1.20
Purification and properties of a gelatin-specific neutral protease from human skin. J Biol Chem (1981) 1.15
Cloning of a complementary DNA for rabbit proactivator. A metalloproteinase that activates synovial cell collagenase, shares homology with stromelysin and transin, and is coordinately regulated with collagenase. Arthritis Rheum (1987) 1.10
Activation of human breast carcinoma collagenase through plasminogen activator. Life Sci (1980) 1.10
Procollagenase activator produced by rabbit uterine cervical fibroblasts. Biochem J (1987) 1.03
The structure of the human skin fibroblast collagenase gene. J Biol Chem (1988) 0.95
Proceedings: Activation of the inactive precursor of collagenase by kallikrein and plasmin. Arch Int Physiol Biochim (1974) 0.89
Stimulation of skin fibroblast collagenase production by a cytokine derived from basal cell carcinomas. J Invest Dermatol (1985) 0.88
Human epidermal plasminogen activator. Characterization, localization, and modulation. Exp Cell Res (1985) 0.85
Sequence of the gene for the constant region of the mu chain of Balb/c mouse immunoglobulin. Gene (1981) 8.45
SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem (1989) 5.64
Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem (1995) 5.57
Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Science (1998) 4.08
H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem (1988) 4.06
Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem (1986) 3.67
A mouse alpha-globin-related pseudogene lacking intervening sequences. Nature (1980) 2.92
The Preparation and Properties of Haemophilus Pertussis Endotoxin. Can Med Assoc J (1940) 2.88
Human 92- and 72-kilodalton type IV collagenases are elastases. J Biol Chem (1991) 2.71
Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. J Clin Invest (1990) 2.56
Human skin collagenase: isolation of precursor and active forms from both fibroblast and organ cultures. Biochemistry (1977) 2.39
Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem (1992) 2.34
COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis (1998) 2.30
The collagen substrate specificity of human skin fibroblast collagenase. J Biol Chem (1981) 2.26
The metabolism of galactose: The behaviour of the rat towards moderate amounts of galactose. Biochem J (1934) 2.21
Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc Natl Acad Sci U S A (1989) 2.12
Collagenase production by human skin fibroblasts. Biochem Biophys Res Commun (1975) 2.12
Two Antibiotics Produced by a Streptomyces. J Bacteriol (1947) 2.08
The allosteric ligand site in the Vmax-type cooperative enzyme phosphoglycerate dehydrogenase. Nat Struct Biol (1995) 2.07
Human skin collagenase. Isolation and mechanism of attack on the collagen molecule. Biochim Biophys Acta (1968) 2.05
A monoclonal antibody against human thrombospondin inhibits platelet aggregation. Proc Natl Acad Sci U S A (1985) 2.04
Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases. J Biol Chem (1990) 1.98
Isolation and characterization of a heparin-binding domain from the amino terminus of platelet thrombospondin. J Biol Chem (1984) 1.94
Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells. Proc Natl Acad Sci U S A (1987) 1.89
Primary structural requirements for the enzymatic formation of the N-glycosidic bond in glycoproteins. Studies with natural and synthetic peptides. J Biol Chem (1979) 1.85
Cerebral autoregulation following minor head injury. J Neurosurg (1997) 1.84
Plasma membrane-dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J Biol Chem (1993) 1.83
The activation of human skin fibroblast procollagenase. Sequence identification of the major conversion products. J Biol Chem (1987) 1.78
Location of the initial cleavage sites in mouse pre-rRNA. Mol Cell Biol (1983) 1.77
Scleroderma: increased biosynthesis of triple-helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts in culture. J Clin Invest (1979) 1.73
Connective tissue nevi of the skin. Clinical, genetic, and histopathologic classification of hamartomas of the collagen, elastin, and proteoglycan type. J Am Acad Dermatol (1980) 1.71
Integrin alpha 2 beta 1 (VLA-2) mediates reorganization and contraction of collagen matrices by human cells. Cell (1991) 1.65
Antitumor activity of sorafenib in FLT3-driven leukemic cells. Leukemia (2007) 1.65
Mapping of epitopes for monoclonal antibodies against human platelet thrombospondin with electron microscopy and high sensitivity amino acid sequencing. J Cell Biol (1985) 1.62
M protein and protein F act as important determinants of cell-specific tropism of Streptococcus pyogenes in skin tissue. J Clin Invest (1994) 1.60
Cutaneous mycobacteriosis: analysis of 34 cases with a new classification of the disease. Medicine (Baltimore) (1981) 1.57
Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing. J Clin Invest (1993) 1.56
Increased collagen cross-linkages in experimental diabetes: reversal by beta-aminopropionitrile and D-penicillamine. Diabetes (1980) 1.56
Human skin collagenase: relationship to the pathogenesis of epidermolysis bullosa dystrophica. J Invest Dermatol (1969) 1.54
Thymus and the production of antibody-plaque-forming cells. Nature (1965) 1.54
Inhibition of human skin collagenase by human serum. J Lab Clin Med (1970) 1.53
Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds. J Clin Invest (1994) 1.52
Human skin fibroblast collagenase: chemical properties of precursor and active forms. Biochemistry (1978) 1.47
The nucleotide sequence of the serA gene of Escherichia coli and the amino acid sequence of the encoded protein, D-3-phosphoglycerate dehydrogenase. J Biol Chem (1986) 1.47
Prevalence of iron deficiency in rural pre-school children in Northern Ireland. Br J Gen Pract (1990) 1.45
Human fibroblast collagenase: glycosylation and tissue-specific levels of enzyme synthesis. Proc Natl Acad Sci U S A (1986) 1.44
Effect of neonatal thymectomy on the induction of sarcomata in C57 BL mice. Nature (1965) 1.42
Human skin fibroblast procollagenase: mechanisms of activation by organomercurials and trypsin. Biochemistry (1983) 1.39
Adenovirus E1A represses protease gene expression and inhibits metastasis of human tumor cells. Oncogene (1990) 1.39
Induction of cyclooxygenase-2 by the activated MEKK1 --> SEK1/MKK4 --> p38 mitogen-activated protein kinase pathway. J Biol Chem (1998) 1.38
Enzyme-linked immunosorbent assay for human skin collagenase. Coll Relat Res (1983) 1.38
Role of cysteine in regulating morphogenesis and mitochondrial activity in the dimorphic fungus Histoplasma capsulatum. Proc Natl Acad Sci U S A (1981) 1.38
A specific inhibitor of vertebrate collagenase produced by human skin fibroblasts. J Biol Chem (1979) 1.37
Human skin fibroblast collagenase: interaction with substrate and inhibitor. Coll Relat Res (1985) 1.37
Expression of 92-kD type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1. J Clin Invest (1993) 1.36
Neutral proteinases of human mononuclear phagocytes. Cellular differentiation markedly alters cell phenotype for serine proteinases, metalloproteinases, and tissue inhibitor of metalloproteinases. J Immunol (1991) 1.34
Localization of the hemagglutinating activity of platelet thrombospondin to a 140 000-dalton thermolytic fragment. Biochemistry (1984) 1.33
Quantitation and immunocytochemical localization of human skin collagenase in basal cell carcinoma. J Invest Dermatol (1977) 1.33
Modulation of keratinocyte proliferation in vitro by endogenous prostaglandin synthesis. J Clin Invest (1986) 1.31
Human skin collagenase. The role of serum alpha-globulins in the control of activity in vivo and in vitro. Proc Natl Acad Sci U S A (1971) 1.31
Human skin collagenase: localization and distribution in normal human skin. J Invest Dermatol (1969) 1.28
Alanine scanning mutagenesis and functional analysis of the fibronectin-like collagen-binding domain from human 92-kDa type IV collagenase. J Biol Chem (1992) 1.28
Increasing incidence of infantile hypertrophic pyloric stenosis, 1971-1983. Ir Med J (1986) 1.26
Mechanisms of UV-induced inflammation. J Invest Dermatol (1993) 1.25
Effects of anti-thrombospondin monoclonal antibodies on the agglutination of erythrocytes and fixed, activated platelets by purified thrombospondin. Biochemistry (1985) 1.21
Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J Invest Dermatol (1991) 1.21
Recurrent intracranial Masson's vegetant intravascular hemangioendothelioma. Case report and review of the literature. J Neurosurg (1999) 1.18
Human skin fibroblast collagenase. Assessment of activation energy and deuterium isotope effect with collagenous substrates. J Biol Chem (1981) 1.17
Isolation of the fibrinogen-binding region of platelet thrombospondin. Biochem Biophys Res Commun (1984) 1.17
Purification and properties of a gelatin-specific neutral protease from human skin. J Biol Chem (1981) 1.15
Characterization of a cDNA encoding the heparin and collagen binding domains of human thrombospondin. Proc Natl Acad Sci U S A (1986) 1.15
Platelet-derived collagenase inhibitor: characterization and subcellular localization. Proc Natl Acad Sci U S A (1985) 1.15
1-Phenyl-5-pyrazolyl ureas: potent and selective p38 kinase inhibitors. Bioorg Med Chem Lett (2000) 1.14